Alisa Petkevich was born on September 26, 1991, in Omsk, USSR. She is a Russian laboratory researcher and geneticist with extensive experience in cell culture and molecular biology techniques.

Work Experience:
Since December 2018, Alisa has been working as a lab researcher at the N. N. Blokhin Russian Cancer Center. Her role involves working with cell lines and cultures, isolating and cultivating cell cultures, and performing advanced techniques such as flow cytometry, cell viability testing, and cell sorting.

In December 2019, Alisa joined RUDN University (Peoples’ Friendship University of Russia) as a research assistant. Her work includes routine genetic techniques such as DNA, RNA, and miRNA isolation, PCR, and related methodologies.

Since November 2017, Alisa has also been employed as a full-time laboratory geneticist at LLC Life Impulse, further honing her expertise in genetics.

Education:
Alisa completed her residency in laboratory genetics at RUDN University in 2019. Prior to that, she undertook a postgraduate specialization in internal diseases at the same university. She pursued PhD studies at the N. N. Blokhin Russian Cancer Research Center from 2015 to 2018 and graduated from I.M. Sechenov First Moscow State Medical University in 2015 with a medical degree.

Professional Achievements:
Alisa has actively contributed to the field through her participation in international conferences:
– In 2018, she presented a poster titled “Cells Interaction and Modifications via Exosomes” at the ICEV Conference in Barcelona.
– She also presented a poster titled “MicroRNA Profile as Prognostic Marker for HCC Development” at EASL in the same year.

– In 2016, she delivered an oral report titled “MRD and Inhibitors of Immune Checkpoints” at the 13th Haematopoiesis Immunology Conference in Budapest.

– Additionally, she presented a report titled “The First Step in the Definition of Prognostic Biomarkers for Adverse Effects After Treatment with Inhibitors of Immune Checkpoints” at ISCOMS in Groningen, Holland.

Alisa’s dedication to scientific research and her contributions to the field of genetics highlight her expertise and commitment to advancing medical science.